Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bega Group is a leading Australian food and beverage company with a significant presence in the dairy and nutritional ingredients market. Through its Bega Bio division, the company specializes in the extraction of high-value bioactive proteins, most notably Lactoferrin, which is supplied to the pharmaceutical, nutraceutical, and infant formula industries globally. Bega operates a sophisticated network of manufacturing facilities that adhere to stringent quality standards, including GMP for its nutritional products. The company's portfolio spans from iconic consumer brands like Vegemite to advanced bio-nutrient solutions, positioning it as a key player in the intersection of food science and health. It is publicly traded on the Australian Securities Exchange and has expanded significantly through strategic acquisitions, including Lion Dairy & Drinks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bega Cheese.